Canadian Clinical Study Sites Re-Commence Bladder Cancer Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/9/2026

1. AAPL
2. NUVL
3. SPY
4. RBRK
5. GOOGL
6. APLD
7. USO
8. CPB
9. SPCX
10. MTN

Go back to Canadian Clinical Study Sites Re-Commence Bladder Cancer Study
Theralase Technologies Inc Ordinary Share (AMEX: TLTFF) Delayed: 0.17 --0 (-0%)
Previous Close $0.17    52 Week High $0.35 
Open $0.17    52 Week Low $0.18 
Day High $0.18    P/E N/A 
Day Low $0.17    EPS $0.00 
Volume 32,163